About Our Innovation Prize 

Boehringer Ingelheim’s Innovation Prize was established in Boston in 2015 to recognize the challenge and dedication of life-science entrepreneurs in advancing new ideas and new science.

Sponsored by Boehringer Ingelheim, the Prize* facilitates business growth, allowing recipients to focus on developing the next generation of breakthrough medicines. The Prize is established in the USA, Japan, China and various innovation ecosystems in Europe, including Austria. 

We will announce the next call for the Innovation Prize in this page and through our LinkedIn channel.  

Celebrating Our Innovation Prize Winners in Austria

Recent winners have included a:head bio in 2021, recognized for its work in growing cerebral organoids to conduct research into therapeutics for central nervous system disorders; and Proxygen in 2020, a startup developing a unique molecular glue degrader discovery platform.

Innovation Prize Winners

Since its inception in 2015, more than 20 companies have been awarded prizes with a value of more than 1,000,000 Euro.  We are proud to honor all the recipients of our Innovation Prize below: 

*Prizes are adapted according to location and include, for example, free lab space for one year.
 

2022

Bordeaux, France

Boston, USA

Kobe, Japan

Dallas USA

New York, USA

Shanghai, China

Valanx Biotech

Rubik Therapeutics

Gap Junction Co., Ltd

GenerAb

Deliberate AI

Degron Therapeutics; Aerosol Biotech

2021

 

Boston, USA

Heidelberg, Germany

New York, USA

San Diego, USA

Shanghai, China

Tokyo, Japan

Vienna, Austria

Thymmune Therapeutics

Medraxa Therapeutics

Synthis Therapeutics

Enable Therapeutics

Juventis Therapeutics

Cellusion Inc.

a:head bio

2020

 

San Diego, USA

Shanghai, China

Tokyo, Japan

Vienna, Austria

Ocelot Bio

Transcend Cytotherapy; Delonix Bioworks

STAND Therapeutics Co. Ltd

Proxygen

2019

 

Boston, USA

New York, USA

San Diego, USA

Tokyo, Japan

Axonis Therapeutics Ltd

Kodikaz Therapeutic Solutions

Darkwood Pharmaceuticals

Restore Vision

2018

 

Boston, USA

San Diego, USA

Fairbanks Pharmaceuticals

Epitracker

2017

 

Boston, USA

San Diego, USA

Apic Bio

Rift Biotherapeutics

2016Boston, USAAbexxa Biologics
2015Boston, USAKleo Pharmaceuticals
Fostering Science

Creating breakthrough medicines that change patients’ lives starts with a commitment to identify the health challenges of the future and advance emerging science. As an independent and family- owned company, we have the freedom to pursue our long- term vision, with distinctive approaches that enable new journeys of discovery today that will transform the lives of patients in generations to come.

Venture Fund

Find out more about how our Venture Fund team drives innovation through strategic investments in early-stage science and technology.

Related Press Releases